Home

Market Capitalization of Astrazeneca Pharma India Ltd

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

Market Cap

₹ 22344.63 crore

Last updated on: Sep 02, 2025

Key Highlights

  • The Market Cap of Astrazeneca Pharma India Ltd is ₹ 22344 crore as of 02 Sep 25 .
  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 9070 as of 03 Sep 12:35 .
  • The Dividend Payouts of Astrazeneca Pharma India Ltd changed from ₹ 2 on Aug 20, 2020 to ₹ 32 on Jul 18, 2025 . This represents a CAGR of 58.74% over 6 years.
Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

Share Price

₹ 9070

132.15 (1.48%)

stock direction

Last updated on: Sep 03, 2025

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Sep 20258937.85
01 Sep 20258751.75
29 Aug 20258469.45
28 Aug 20258322.7
26 Aug 20258014.9
25 Aug 20258297.1
22 Aug 20258431.65
21 Aug 20258397.35
20 Aug 20258450.65
19 Aug 20258472.9

SWOT Analysis Of Astrazeneca Pharma India Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Astrazeneca Pharma India Ltd

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Astrazeneca Pharma India Ltd

No data available

Historical P/E Ratio of Astrazeneca Pharma India Ltd

No data available

* All values are in %

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical EBITDA of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Astrazeneca Pharma India Ltd

No data available

* All values are in

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

Astrazeneca Pharma India Ltd News Hub

AstraZeneca Pharma fixes record date for final dividend

AstraZeneca Pharma India has fixed 18 July 2025 as record date for final dividend for FY 2024-25. Th

Read more

12 Jul 25

AstraZeneca Pharma to launch Eculizumab (Soliris) in India

 AstraZeneca Pharma India announced that it will launch Eculizumab (Soliris) in August 2025 in India

Read more

06 Aug 25

Astrazeneca Pharma India standalone net profit rises 47.54% in the March 2025 quarter

Net profit of Astrazeneca Pharma India rose 47.54% to Rs 58.25 crore in the quarter ended March 2025

Read more

31 May 25

Volumes soar at Astrazeneca Pharma India Ltd counter

Max Healthcare Institute Ltd, Godrej Consumer Products Ltd, Mphasis Ltd, Indraprastha Gas Ltd are am

Read more

02 Jun 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Astrazeneca Pharma India Ltd Market Cap

What is the market cap of Astrazeneca Pharma India Ltd?

As of September 3, 2025, Astrazeneca Pharma India Ltd has a market capitalization of ₹22344.63, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Astrazeneca Pharma India Ltd's market capitalization?

Astrazeneca Pharma India Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Astrazeneca Pharma India Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Astrazeneca Pharma India Ltd's market capitalization change?

Astrazeneca Pharma India Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions